Ishida Masaki, Kato Noriyuki, Hirano Tadanori, Cheng Shao Hua, Shimono Takatsugu, Takeda Kan
Department of Radiology, Mie University Hospital, Mie, Japan.
J Vasc Interv Radiol. 2004 Apr;15(4):361-7. doi: 10.1097/01.rvi.0000121412.46920.fc.
To evaluate short- and midterm results of the endovascular repair of thoracic aortic aneurysm (TAA) with the use of custom-made stent-grafts.
Between May 1997 and May 2003, 40 patients with TAA (26 degenerative/atherosclerotic, seven dissection-related, three traumatic, two mycotic, one anastomotic, and one penetrating ulcer) underwent endovascular stent-graft placement. The mean age of the patients (29 male and 11 female) was 67.2 years. Twenty-four of the 40 patients (60%) were judged not to be good candidates for conventional open repair. Stent-graft placement was performed in the angiography suite with general anesthesia and transient cardiac arrest or induced hypotension. Custom-made stent-grafts were used in all patients. Four of the 40 patients (10%) underwent preliminary extra-anatomic bypass surgery to provide a sufficiently long landing zone. The mean follow-up period was 16.7 months (range, 1-65 months).
The technical success rate was 97.5% and the early mortality rate was 2.5% (one out of 40 patients). There were four late deaths (two procedure-related). Survival rates were 84.2%+/-6.6% at 1 year and 84.2%+/-6.6% at 2 years. Survival rates were not significantly different between surgical candidates and non-surgical candidates (P =.423). Intraprocedural complications included access artery complications in nine patients and bleeding in three patients. Postoperative complications included early aneurysmal expansion in one patient, pneumonia in one patient, wound infection in one patient, stroke in three patients, paraplegia in one patient, respiratory insufficiency in two patients, aortoesophageal fistula in one patient, and late aneurysmal expansion in three patients. The rates of freedom from first additional intervention were 91.0%+/-6.7% at 1 year and 74.5%+/-11.9% at 2 years. The rates of freedom from second additional intervention was 100% at 2 years. The rates of freedom from treatment failure were 84.7%+/-7.6% at 1 year and 69.3%+/-11.6% at 2 years.
Endovascular repair of TAA with a custom-made stent-graft is a safe and effective alternative to open repair and continues to play an important role. However, careful follow-up is mandatory to manage complications.
评估使用定制支架型人工血管进行胸主动脉瘤(TAA)血管腔内修复的短期和中期结果。
1997年5月至2003年5月期间,40例TAA患者(26例退行性/动脉粥样硬化性、7例与夹层相关、3例创伤性、2例霉菌性、1例吻合口性和1例穿透性溃疡)接受了血管腔内支架型人工血管置入术。患者平均年龄67.2岁(男29例,女11例)。40例患者中有24例(60%)被判定不适合传统开放修复。在血管造影室全身麻醉并短暂心脏停搏或诱导性低血压的情况下进行支架型人工血管置入。所有患者均使用定制支架型人工血管。40例患者中有4例(10%)接受了初步的解剖外旁路手术以提供足够长的锚定区。平均随访期为16.7个月(范围1 - 65个月)。
技术成功率为97.5%,早期死亡率为2.5%(40例患者中的1例)。有4例晚期死亡(2例与手术相关)。1年生存率为84.2%±6.6%,2年生存率为84.2%±6.6%。手术候选者和非手术候选者的生存率无显著差异(P = 0.423)。术中并发症包括9例患者的入路动脉并发症和3例患者的出血。术后并发症包括1例患者早期动脉瘤扩张、1例患者肺炎、1例患者伤口感染、3例患者中风、1例患者截瘫、2例患者呼吸功能不全、1例患者主动脉食管瘘和3例患者晚期动脉瘤扩张。首次额外干预的无发生率在1年时为91.0%±6.7%,2年时为74.5%±11.9%。第二次额外干预的无发生率在2年时为100%。治疗失败的无发生率在1年时为84.7%±7.6%,2年时为69.3%±11.6%。
使用定制支架型人工血管进行TAA血管腔内修复是开放修复的一种安全有效的替代方法,并继续发挥重要作用。然而,必须进行仔细的随访以处理并发症。